CIRM Management Stumbling at Routine Tasks
Only four business days remain before a key California stem cell agency meeting that will deal with its financial future and the future of its departing chairman, Robert Klein, but the $3 billion state enterprise still is not providing any information to the public on those matters beyond cryptic hints.
The failure to provide the information represents …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.